Update: Alector Shares Rise After Licensing AL050 Program to Roche's Genentech

MT newswire2026/10/05 19:04

03:04 PM EDT, 10/05/2026 (MT Newswires) -- (Updates with the latest stock movement in the first paragraph and headline.) Alector (ALEC) shares were up more than 18% in Monday trading after the company said it entered an exclusive global licensing agreement with Genentech, a Roche firm, for the development and commercialization of its AL050 program targeting Parkinson's disease. Under the deal, Alector said it will receive $100 million upfront and is eligible for up to $1.17 billion in development, regulatory and commercial milestones, as well as tiered royalties on net sales. Genentech will handle development, regulatory, manufacturing and commercialization globally, the company said. Alector said it will retain ownership of its antibody blood-brain-barrier transport platform and rights to use it across its wholly owned pipeline. Price: 2.14, Change: +0.33, Percent Change: +18.23

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Rumor: Tesla (TSLA.US) and SpaceX (SPCX.US) plan Terafab monthly production of one million wafers, feasibility questioned

According to reports, Tesla (TSLA.US) and SpaceX (SPCX.US) plan to achieve a production capacity of 1 million semiconductor wafers per month at the proposed Terafab factory starting in 2032.

智通财经•2026/11/09 11:09

Eurozone Sentix Investor Confidence Index slips to 2.4 in November from 2.7 in October

FXStreet•2026/11/09 10:57

The UK Financial Conduct Authority allows banks to submit applications for crypto-related businesses.

AiCoin•2026/11/09 10:45

SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries

A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.

华尔街见闻•2026/11/09 10:26